Transfusion thresholds and other strategies for guiding red blood cell transfusion.
Jeffrey L Carson, Simon J Stanworth, Jane A Dennis...
https://pubmed.ncbi.nlm.nih.gov/41114449/Actively Recruiting
Led by Unity Health Toronto · Updated on 2024-11-21
1440
Participants Needed
54
Research Sites
26 weeks
Total Duration
This trial investigates transfusion strategies for younger patients aged 18 to 65 undergoing cardiac surgery with the use of cardiopulmonary bypass. It compares two common approaches to red blood cell transfusion thresholds to determine which is better for patients at moderate to high risk, focusing on important health outcomes after surgery. Participants are randomly assigned to one of two groups. One group receives a restrictive transfusion strategy, where transfusions are given only if hemoglobin levels drop below 75 gL during or after surgery. The other group follows a liberal transfusion strategy, with transfusions given at higher hemoglobin thresholds during surgery, in the intensive care unit, or on the ward. The study is open-label and conducted at multiple international centers. During the trial, researchers monitor participants for events such as death, heart attacks, kidney failure requiring dialysis, and neurological problems up to six months after surgery. They also track hospital stay length, infections, mechanical ventilation time, and other complications. Participants are followed closely through hospital discharge and for several months afterward to collect this important information.
CONDITIONS
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
D
David Mazer, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Unity Health Toronto
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Restrictive Transfusion (Hb < 75 g/L) | Liberal Transfusion (Hb < 95 g/L OR < 85 g/L) |
|---|---|---|
| What it is | Red‑cell transfusion is given intraoperatively and/or postoperatively when hemoglobin falls below 75 g/L (7.5 g/dL). | Transfusion is administered intra‑ or post‑operatively when hemoglobin drops below 95 g/L (9.5 g/dL) in operating room or ICU, or below 85 g/L (8.5 g/dL) on ward. |
| Role in trial | Investigational transfusion threshold tested for safety and outcomes. | Comparator transfusion threshold used as standard practice comparator. |
| Primary use | To determine whether a lower hemoglobin threshold reduces transfusion while maintaining safety. | Represents a more liberal transfusion threshold for comparison. |
| How it is given or performed | Transfusion given when hemoglobin falls below threshold determined by surgical or critical setting. | Transfusion given based on higher hemoglobin threshold depending on patient location (operating room, ICU, ward). |
| Evidence status | TRICS III cardiac surgery trial showed noninferiority of restrictive versus liberal strategy for composite outcomes with less transfusion. | Liberal strategy used as reference; outcomes similar to restrictive but involves more transfusions. |
| Important risks | No excess risk observed in outcomes compared with liberal strategy in cardiac surgery population. | Higher transfusion exposure may increase risks associated with blood products. |
| Important limitations | Evidence largely pertains to moderate to high‑risk adult cardiac surgery; generalizability to other populations or lower‑risk groups may be limited. | Threshold may not reflect current practice in all centres and leads to more transfusions without demonstrated benefit. |
| Patient impact | Reduces exposure to blood transfusions while achieving similar short‑term clinical outcomes. | Involves more transfusions without clear advantage in major outcomes. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to hospital discharge or 28 days postoperatively, whichever comes first
Participants undergo planned cardiac surgery using cardiopulmonary bypass and receive transfusions according to assigned transfusion thresholds during and immediately after surgery.
Daily assessments during hospital stay
Duration - Up to 6 months after cardiac surgery
Participants are monitored for up to 6 months after cardiac surgery for health outcomes including mortality, myocardial infarction, renal failure, neurological events, and hospital visits.
Regular follow-up visits or contacts during 6 months
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jeffrey L Carson, Simon J Stanworth, Jane A Dennis...
https://pubmed.ncbi.nlm.nih.gov/41114449/Jeffrey L Carson, Simon J Stanworth, Jane A Dennis...
https://pubmed.ncbi.nlm.nih.gov/34932836/Unity Health Toronto
Lead Sponsor